{"id":446587,"title":"Notice of Intent to Amend the Prescription Drug List: Metamizole (dipyrone) - Canada.ca - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T12:19:27.245000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/intent-amend-metamizole.html?wbdisable=false","snippet":"Notice of Intent to Amend the Prescription Drug List: Metamizole (dipyrone) January 18, 2022 Our file number: 22-100544-803 The purpose of this Notice of Intent to Amend is to announce that metamizole (also known as ‘dipyrone’) will be added to the Prescription Drug List (PDL).…","rawSnapshotUrl":"/api/snapshots/raw/446587","browseUrl":"https://replay.healtharchive.ca/job-6/20260103121927/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/intent-amend-metamizole.html?wbdisable=false#ha_snapshot=446587","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}